Exact Sciences: 2Q Earnings Snapshot
MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Monday reported a loss of $38.4 million in its second quarter.
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 30 cents.
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 56 cents per share.
The molecular diagnostics company posted revenue of $199.9 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $181.9 million.
Exact Sciences expects full-year revenue in the range of $800 million to $810 million.
Exact Sciences shares have increased 87% since the beginning of the year. The stock has more than doubled in the last 12 months.